Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$9.80 -0.23 (-2.29%)
Closing price 06/23/2026 04:00 PM Eastern
Extended Trading
$9.99 +0.19 (+1.98%)
As of 05:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DRTS vs. WRBY, TMDX, ESTA, AXGN, and LMAT

Should you buy Alpha Tau Medical stock or one of its competitors? MarketBeat compares Alpha Tau Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Tau Medical include Warby Parker (WRBY), TransMedics Group (TMDX), Establishment Labs (ESTA), AxoGen (AXGN), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

How does Alpha Tau Medical compare to Warby Parker?

Warby Parker (NYSE:WRBY) and Alpha Tau Medical (NASDAQ:DRTS) are both medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Warby Parker has a net margin of 0.15% compared to Alpha Tau Medical's net margin of 0.00%. Warby Parker's return on equity of 2.30% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker0.15% 2.30% 1.18%
Alpha Tau Medical N/A -73.23%-52.90%

Warby Parker has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$890.57M3.09$1.64M$0.021,285.50
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

Warby Parker has a beta of 1.96, indicating that its share price is 96% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, indicating that its share price is 19% more volatile than the broader market.

Warby Parker presently has a consensus target price of $29.50, indicating a potential upside of 14.74%. Alpha Tau Medical has a consensus target price of $12.60, indicating a potential upside of 28.57%. Given Alpha Tau Medical's higher possible upside, analysts plainly believe Alpha Tau Medical is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Warby Parker had 8 more articles in the media than Alpha Tau Medical. MarketBeat recorded 10 mentions for Warby Parker and 2 mentions for Alpha Tau Medical. Warby Parker's average media sentiment score of 0.90 beat Alpha Tau Medical's score of 0.00 indicating that Warby Parker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 16.8% of Warby Parker shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Warby Parker beats Alpha Tau Medical on 13 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

In the previous week, TransMedics Group had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 5 mentions for TransMedics Group and 2 mentions for Alpha Tau Medical. TransMedics Group's average media sentiment score of 0.74 beat Alpha Tau Medical's score of 0.00 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has a net margin of 27.04% compared to Alpha Tau Medical's net margin of 0.00%. TransMedics Group's return on equity of 22.38% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group27.04% 22.38% 8.46%
Alpha Tau Medical N/A -73.23%-52.90%

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 6.9% of TransMedics Group shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

TransMedics Group has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$605.49M4.21$190.29M$4.4016.78
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

TransMedics Group has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, suggesting that its stock price is 19% more volatile than the broader market.

TransMedics Group currently has a consensus target price of $134.50, suggesting a potential upside of 82.18%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential upside of 28.57%. Given TransMedics Group's stronger consensus rating and higher possible upside, research analysts plainly believe TransMedics Group is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.46
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

TransMedics Group beats Alpha Tau Medical on 14 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Alpha Tau Medical (NASDAQ:DRTS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Establishment Labs currently has a consensus price target of $87.14, indicating a potential upside of 0.15%. Alpha Tau Medical has a consensus price target of $12.60, indicating a potential upside of 28.57%. Given Alpha Tau Medical's higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than Establishment Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

Alpha Tau Medical has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$211.08M12.13-$51.06M-$1.49N/A
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

In the previous week, Establishment Labs had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 5 mentions for Establishment Labs and 2 mentions for Alpha Tau Medical. Establishment Labs' average media sentiment score of 1.31 beat Alpha Tau Medical's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Alpha Tau Medical has a net margin of 0.00% compared to Establishment Labs' net margin of -19.05%. Alpha Tau Medical's return on equity of -73.23% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-19.05% -218.77% -12.31%
Alpha Tau Medical N/A -73.23%-52.90%

Establishment Labs has a beta of 1.11, suggesting that its share price is 11% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Summary

Alpha Tau Medical beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to AxoGen?

Alpha Tau Medical (NASDAQ:DRTS) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 2.4% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, AxoGen had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 3 mentions for AxoGen and 2 mentions for Alpha Tau Medical. AxoGen's average media sentiment score of 1.61 beat Alpha Tau Medical's score of 0.00 indicating that AxoGen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
AxoGen
2 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
AxoGen$225.21M10.55-$15.70M-$0.64N/A

Alpha Tau Medical presently has a consensus price target of $12.60, suggesting a potential upside of 28.57%. AxoGen has a consensus price target of $46.50, suggesting a potential upside of 4.05%. Given Alpha Tau Medical's higher possible upside, equities research analysts clearly believe Alpha Tau Medical is more favorable than AxoGen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
AxoGen
1 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.73

Alpha Tau Medical has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.12, suggesting that its share price is 12% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -13.21%. AxoGen's return on equity of -9.63% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
AxoGen -13.21%-9.63%-6.26%

Summary

AxoGen beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to LeMaitre Vascular?

Alpha Tau Medical (NASDAQ:DRTS) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 2 articles in the media. Alpha Tau Medical's average media sentiment score of 0.00 beat LeMaitre Vascular's score of -0.12 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LeMaitre Vascular
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

LeMaitre Vascular has a net margin of 24.35% compared to Alpha Tau Medical's net margin of 0.00%. LeMaitre Vascular's return on equity of 15.36% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
LeMaitre Vascular 24.35%15.36%9.78%

LeMaitre Vascular has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
LeMaitre Vascular$249.60M8.42$57.73M$2.7133.93

Alpha Tau Medical currently has a consensus price target of $12.60, suggesting a potential upside of 28.57%. LeMaitre Vascular has a consensus price target of $112.60, suggesting a potential upside of 22.46%. Given Alpha Tau Medical's higher probable upside, equities research analysts plainly believe Alpha Tau Medical is more favorable than LeMaitre Vascular.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
LeMaitre Vascular
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.75

Alpha Tau Medical has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Summary

LeMaitre Vascular beats Alpha Tau Medical on 10 of the 14 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$905.97M$7.05B$6.44B$12.38B
Dividend YieldN/A1.28%2.69%5.83%
P/E Ratio-14.6348.6524.6623.99
Price / SalesN/A76.50527.00106.82
Price / CashN/A24.7844.8254.51
Price / Book11.147.1310.756.50
Net Income-$42.63M$159.20M$3.56B$336.88M
7 Day Performance1.98%-0.98%1.00%-0.14%
1 Month Performance-2.39%-1.97%0.43%0.77%
1 Year Performance229.97%5.08%29.69%28.49%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
3.0385 of 5 stars
$9.80
-2.3%
$12.60
+28.6%
+228.9%$905.97MN/AN/A80
WRBY
Warby Parker
3.7191 of 5 stars
$25.17
-4.6%
$29.50
+17.2%
+16.8%$2.83B$871.91M1,258.884,036
TMDX
TransMedics Group
4.6366 of 5 stars
$75.82
+0.5%
$134.00
+76.7%
-42.1%$2.61B$605.49M17.23210
ESTA
Establishment Labs
1.5838 of 5 stars
$82.57
-1.9%
$87.14
+5.5%
+137.9%$2.48B$211.08MN/A1,004
AXGN
AxoGen
1.9453 of 5 stars
$43.40
-0.8%
$46.50
+7.1%
+356.5%$2.33B$225.21MN/A450

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners